BRAF and thyroid gland papillary carcinoma: Not all studies have consistently shown this mutation to be associated with higher risk for a more aggressive clinical course,38–40 nor is the clinical ramification of the BRAF mutation identical in all subtypes of papillary thyroid cancer.41,42